News of the approval of the new Alzheimer’s drug has hit the headlines this week. Lecanemab has been approved by the MHRA, the UK’s regulator, but has been rejected by NICE so it will not be available on the NHS. Lecanemab is part of a new class of drugs that is emerging. It slows the […]

A new study is using small amounts of electricity to stimulate the brain in people with mild cognitive impairment or Alzheimer’s disease. The aim is to see if this can help keep the part of the brain which is responsible for memory active, whilst delaying symptoms of Alzheimer’s disease. The ‘Causal role of neural activity […]

Healthy volunteers aged 40 and over are being invited to take part in a new study using virtual reality to assess how well people navigate their surroundings.  The idea is that this will help researchers spot early signs of Alzheimer’s disease.  What does the study involve? In the first session participants will play a game […]

A study into whether brushing teeth daily can slow memory loss in people with early stage Alzheimer’s disease is recruiting participants through Join Dementia Research. The MySmile study, led by the University of Bristol and supported by the National Institute for Health and Care Research (NIHR), is recruiting people aged 60 and over with either […]

People with Down’s syndrome have an increased risk of developing Alzheimer’s disease. This is because most people with Down’s syndrome will have clumps of amyloid and tau proteins in their brains by the age of 40 – these are believed to cause Alzheimer’s disease. Two thirds of people with Down’s syndrome develop Alzheimer’s by the […]

World Alzheimer’s Month took place in September. This year’s theme was ‘Never too early, never too late’, which focused on raising awareness of risk factors for Alzheimer’s disease and potentially preventing the onset of dementia. Throughout the month, Join Dementia Research celebrated patients, members of the public, healthcare professionals and researchers involved in research. Here […]

A Sussex woman has spoken about losing her grandfather to dementia and how this inspired her to get involved in research. Rianna Patterson, of Hastings, lost her grandfather, Terry Vidal, to dementia in 2013. Following his death, she has been involved in dementia research. This included working with a National Institute for Health and Care […]

A former Police Community Support Officer (PCSO) has spoken about how volunteering for studies through Join Dementia Research has given him a sense of purpose after his Alzheimer’s disease diagnosis.  Peter Middleton from Northamptonshire was diagnosed with early onset Alzheimer’s disease in 2018, aged 64.  Diagnosis Peter said: “I had been a Police Community Support […]

A new drug has been hailed as a scientific breakthrough in treating Alzheimer’s disease, following the publication of final trial results in the medical journal, JAMA.  The findings show donanemab can successfully slow down decline in memory and thinking by 35 per cent among people with early-stage Alzheimer’s Disease. The drug’s ability to slow down […]

The findings of a research study that discovered a treatment for early stage Alzheimer’s disease have been hailed as “momentous” by Alzheimer’s Research UK.  The new treatment, lecanemab, is the first drug to slow cognitive decline in people with early signs of the condition. The CLARITY-AD study enrolled 1,795 patients with early-stage Alzheimer’s globally, including Join […]